Article
Small molecule modulators of cystic fibrosis transmembrane conductance regulator (CFTR): Structure, classification, and mechanisms.
European journal of medicinal chemistry - 5 Feb 2024
Cao Luyang, Wu Yong, Gong Yanchun, Zhou Qingfa
Abstract excerpt
The advent of small molecule modulators targeting the cystic fibrosis transmembrane conductance regulator (CFTR) has revolutionized the treatment of persons with cystic fibrosis (CF) (pwCF). Presently, these small molecule CFTR modulators have gained approval for usage in approximately 90 % of adult pwCF. Ongoing drug development endeavors are focused on optimizing the therapeutic benefits while mitigating...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
